Science Explorer Back to mapMap
Institution · AlphaNet

Most cited papers from AlphaNet

What are the most cited papers from AlphaNet?

The most cited paper from AlphaNet is "Effects of a Disease Management Program in Individuals with Alpha-1 Antitrypsin Deficiency" (Michael Campos, Saleh Alazemi, Guoyan Zhang et al., 2009), with 54 citations. Next come "Exacerbations in subjects with alpha-1 antitrypsin deficiency receiving augmentation therapy" (43) and "Clinical Characteristics of Subjects With Symptoms of α 1 -Antitrypsin Deficiency Older Than 60 Years" (35).

Showing 30 of 30 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Effects of a Disease Management Program in Individuals with Alpha-1 Antitrypsin Deficiency Michael Campos, Saleh Alazemi, Guoyan Zhang et al. · COPD Journal of Chronic Obstructive Pulmonary Disease Open access 2009 54
2 Exacerbations in subjects with alpha-1 antitrypsin deficiency receiving augmentation therapy Michael Campos, Saleh Alazemi, Guoyan Zhang et al. · Respiratory Medicine Open access 22 May 2009 43
3 Clinical Characteristics of Subjects With Symptoms of α 1 -Antitrypsin Deficiency Older Than 60 Years Michael Campos, Saleh Alazemi, Guoyan Zhang et al. · CHEST Journal 19 Nov 2008 35
4 Hyperhomocyst(e)inemia and Hemostatic Factors Pamela J. Schreiner, Kenneth K. Wu, M. RENE MALINOW et al. · Annals of Epidemiology May 2002 27
5 Augmentation Therapy in Alpha-1 Antitrypsin Deficiency Robert A. Sandhaus · COPD Journal of Chronic Obstructive Pulmonary Disease Open access 2009 21
6 Patient Involvement in the Design of a Patient-Centered Clinical Trial to Promote Adherence to Supplemental Oxygen Therapy in COPD Kristen E. Holm, Richard H. Casaburi, Scott Cerreta et al. · Patient 30 Oct 2015 17
7 Genotype is associated with smoking and other key health behaviors among individuals with alpha-1 antitrypsin deficiency-associated lung disease Kristen E. Holm, David M. Mannino, Radmila Choate et al. · Respiratory Medicine Open access Sep 2018 13
8 Quality of Life and Mortality Outcomes for Augmentation Naïve and Augmented Patients with Severe Alpha-1 Antitrypsin Deficiency Paul Ellis, Kristen E. Holm, Radmila Choate et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation Open access 2023 11
9 Health-related Quality of Life in Alpha-1 Antitrypsin Deficiency–associated Chronic Obstructive Pulmonary Disease Radmila Choate, Kristen E. Holm, Robert A. Sandhaus et al. · American Journal of Respiratory and Critical Care Medicine 15 Aug 2023 10
10 Cardiovascular disease in adults with osteogenesis imperfecta: clinical characteristics, care recommendations, and research priorities identified using a modified Delphi technique Lars Folkestad, Siddharth K. Prakash, Sandesh C.S. Nagamani et al. · Journal of Bone and Mineral Research Open access 12 Dec 2024 8
11 Patient-Reported Pulmonary Symptoms, Exacerbations, and Management in a Cohort of Patients With Alpha-1 Antitrypsin Deficiency Radmila Choate, Robert A. Sandhaus, Kristen E. Holm et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation Open access 2022 7
12 Prevalence of Cardiovascular Disease and Rate of Major Adverse Cardiovascular Events in Severe Alpha-1 Antitrypsin Deficiency COPD Paul Ellis, Emily J Bailey, Radmila Choate et al. · International Journal of COPD Open access 2024 5
13 Efficient Resource Management for Game Server Hosting Daniel Rodríguez Martín, Aad van Moorsel, Graham Morgan Conference paper May 2008 5
14 Augmentation Therapy for Alpha-1 Antitrypsin Deficiency: Patient Experiences With Self-Infusion, Home Providers, and Clinics Charlie Strange, Sheri Allison, Jean McCathern et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation Open access 2023 4
15 Home-Based Multicomponent Intervention Increases Exercise Activity and Improves Body Mass Index: Results of a 5-Year Randomized Trial Among Individuals with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease Radmila Choate, David M. Mannino, Kristen E. Holm et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation Open access 2020 4
16 Long-Term SGRQ Stability in a Cohort of Individuals with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease Radmila Choate, Kristen E. Holm, Robert A. Sandhaus et al. · International Journal of COPD Open access Apr 2024 3
17 Characteristics associated with SF-36 in alpha-1 antitrypsin deficiency-associated COPD: a cross-sectional analysis Radmila Choate, Kristen E. Holm, Robert A. Sandhaus et al. · BMC Pulmonary Medicine Open access 18 Mar 2024 3
18 Improving the Likelihood of Identifying Alpha-1 Antitrypsin Deficiency Among Patients With COPD: A Novel Predictive Model Using Real-World Data Daniel N. Pfeffer, Rahul Dhakne, Omnya E Massad et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation Open access 4 Dec 2024 2
19 High BMI and COPD Outcomes in Alpha-1 Antitrypsin Deficiency Michael Campos, Leonard E. Riley, Jorge E. Lascano et al. · CHEST Pulmonary Open access 19 Oct 2024 2
20 Physical and mental health trajectories: A longitudinal SF-36 analysis in Alpha-1 antitrypsin deficiency-associated COPD Radmila Choate, Kristen E. Holm, Robert A. Sandhaus et al. · Respiratory Medicine Open access 14 Oct 2024 2
21 Sleep apnea among individuals with Alpha-1 antitrypsin deficiency-associated lung disease Kristen E. Holm, Robert A. Sandhaus, Sheri Allison et al. · Respiratory Medicine Open access 21 Jun 2025 1
22 Clinical trial attitudes among individuals with Alpha-1 antitrypsin deficiency Kristen E. Holm, Robert A. Sandhaus, Sheri Allison et al. · Respiratory Medicine Open access 23 May 2024 1
23 Pelvic Organ Prolapse and Alpha-1 Antitrypsin Deficiency Erika L. Fuchs, L. Jennifer, Kristen E. Holm et al. · Journal of Women s Health Open access 12 Aug 2026 0
24 Lung Function Variability in Alpha-1 Antitrypsin Deficiency: Implications for Clinical Trials Charlie Strange, Kristen E. Holm, Robert A. Sandhaus et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation Open access 2026 0
25 Gene Therapy: Knowledge, Attitudes, and Preferences Among Individuals with Alpha-1 Antitrypsin Deficiency Matthew M. Stern, Kimberly E. Foil, Charlie Strange et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation Open access 2026 0
26 Gene Therapy: Knowledge, Attitudes, and Preferences Among Individuals with Alpha-1 Antitrypsin Deficiency Kimberly E. Foil, Matthew M. Stern, Charlie Strange et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation Open access 2026 0
27 Chronic Airways Assessment Test: performance and health predictors in the AlphaNet population Radmila Choate, Kristen E. Holm, Robert A Sandhaus et al. · American Journal of Respiratory and Critical Care Medicine Open access 27 Mar 2026 0
28 Severe Obesity and Alpha-1 Antitrypsin Deficiency-Associated COPD: A Dual Burden on Health and Quality of Life Radmila Choate, Kristen E. Holm, Robert A. Sandhaus et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation Open access 2026 0
29 Impact of Coronavirus Disease 2019 and Vaccination Attitudes on Alpha-1 Antitrypsin Deficiency Margaret A. Hay, Kristen E. Holm, Jean McCathern et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation Open access 2023 0
30 Rural Attitudes toward Government Benefit Programs Mary Laidlaw, Peter A. Kindle, Teresa M Thomas et al. · Contemporary Rural Social Work Journal Open access 2018 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.